Adar1 Capital Management, LLC Options Holdings

Adar1 Capital Management, LLC

$500 Billion
Q4 2024

Options Holdings Table

Stock	Option Type	Value	Options Held	Last Trade	Trade History
PTGX Protagonist Therapeutics, Inc Healthcare	CALL	$5.1 Billion	132K	Q4 2024 New holding
XBI Spdr Ser Tr Spdr S&P Biotech E ETFs	CALL	$4.5 Billion	50K	Q4 2024 New holding
JNJ Johnson & Johnson Healthcare	CALL	$1.45 Billion	10K	Q4 2024 New holding
CAPR Capricor Therapeutics, Inc. Healthcare	CALL	$1.31 Billion	95K	Q4 2024 New holding
CYTK Cytokinetics Inc Healthcare	CALL	$710 Million	15.1K	Q3 2024 Added 15000.0%
AKRO Akero Therapeutics, Inc. Healthcare	CALL	$626 Million	22.5K	Q3 2024 New holding
APLT Applied Therapeutics Inc. Healthcare	CALL	$454 Million	530K	Q4 2024 Added 0.02%
BMRN Biomarin Pharmaceutical Inc Healthcare	CALL	$329 Million	5K	Q3 2024 New holding
TARS Tarsus Pharmaceuticals, Inc. Healthcare	CALL	$277 Million	5K	Q3 2024 New holding
RGNX Regenxbio Inc. Healthcare	CALL	$138 Million	17.8K	Q3 2024 New holding
CRVS Corvus Pharmaceuticals, Inc. Healthcare	PUT	$80.3 Million	15K	Q4 2024 New holding
PHAT Phathom Pharmaceuticals, Inc. Healthcare	CALL	$82 Million	10.1K	Q4 2024 New holding
CRVS Corvus Pharmaceuticals, Inc. Healthcare	CALL	$53.5 Million	10K	Q4 2024 New holding
AMLX Amylyx Pharmaceuticals, Inc. Healthcare	CALL	$37.8 Million	10K	Q2 2024 Reduced 86.5%
GOSS Gossamer Bio, Inc. Healthcare	CALL	$18 Million	19.9K	Q4 2024 Reduced 0.51%

Summary

Portfolio
No. of Stocks 214
Current Value $500 Billion
Prior Value $615 Billion
Filing
Period Q4 2024
Filing Date February 13, 2025
Form Type 13F-HR
Activity in Q4 2024
New Purchases 46 stocks
Additional Purchases 54 stocks
Sold out of 0 stocks
Reduced holdings in 66 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.